Exhibit 23.0

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration
Statement on Forms S-8, (File Nos. 333-52796, 333-34780, 33-80036, 33-80048
and 333-62017) and the Registration Statement on Forms S-3 (File Nos.
333-43204, 333-52736, 33-64021, 333-08607, 333-56755, 333-64761 and
333-89341), of AVANT Immunotherapeutics, Inc. (f/k/a TCell Sciences, Inc.) of
our report dated February 2, 2001 relating to the financial statements of
AVANT Immunotherapeutics, Inc. (f/k/a TCell Sciences, Inc.) which appears in
the Annual Report on Form 10-K for the year ended December 31, 2000.



PricewaterhouseCoopers LLP

Boston, Massachusetts
March 27, 2001